Jeremy Reynoso
0000-0002-4376-0101
Publication & Citation Trends
Publications
0 total
Clinical Response of Recurrent Ganglioglioma with BRAF A598_T599insV Mutation to BRAF/MEK Inhibitors (P9-6.011)
Cited by 0
Semantic Scholar
Immunotherapeutic targeting of NY-ESO-1 in malignant meningiomas with TCR-transduced T-cells
Cited by 0
Semantic Scholar
Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors OA
Cited by 24
Semantic Scholar
Abstract B032: Immune landscape of resected brain metastases in patients treated with and without immune checkpoint blockade immunotherapy
Cited by 0
Semantic Scholar
TMIC-02. PRE-SURGICAL IMMUNE CHECKPOINT BLOCKADE RESHAPES THE IMMUNE LANDSCAPE AND SPATIAL ARCHITECTURE OF METASTATIC BRAIN TUMORS OA
Cited by 0
Semantic Scholar
Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma OA
Cited by 188
Semantic Scholar
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma OA
Cited by 59
Semantic Scholar
IMMU-20. SINGLE-CELL RNASEQ OF TUMOR INFILTRATING IMMUNE CELLS FROM NEOADJUVANT ANTI-PD1 TREATED GBM PATIENTS REVEALS GLOBAL TRANSCRIPTIONAL CHANGES AND IMMUNOSUPPRESSIVE ADAPTIVE RESPONSES BY MYELOID CELLS OA
Cited by 0
Semantic Scholar
Research Topics
Glioma Diagnosis and Treatment
(9)
Immune cells in cancer
(4)
Cancer Immunotherapy and Biomarkers
(3)
Renal cell carcinoma treatment
(2)
Immunotherapy and Immune Responses
(2)
Affiliations
University of California, Los Angeles
UCLA Health
UCLA Medical Center
ORCID
The University of Texas Southwestern Medical Center